Showing 1 - 11 results of 11 for search 'Navin Khattry', query time: 0.04s Refine Results
  1. 1
    Introduction of Situation, Background, Assessment, Recommendation into Nursing Practice: A Prospective Study

    Introduction of Situation, Background, Assessment, Recommendation into Nursing Practice: A Prospective Study by Meera S Achrekar, Vedang Murthy, Sadhana Kanan, Rani Shetty, Mini Nair, Navin Khattry

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia

    Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia by Rahul Mojidra, Nilesh Gardi, Bhausaheb Bagal, Navin Khattry, Anant Gokarn, Sachin Punatar, Rukmini Govekar

    Published 2025-01-01
    Get full text
    Article
  3. 3
    Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation

    Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation by Saurabh Kumar Gupta, Subhash Yadav, Deepak Sharma, Santosh Kumar Sandur, Navin Khattry, Jayant Sastri Goda, Vikram Gota

    Published 2025-03-01
    Get full text
    Article
  4. 4
    Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect

    Extract Mitigates Experimental Acute Graft versus Host Disease Without Abrogating Graft Versus Leukemia Effect by Saurabh Kumar Gupta, Dievya Gohil, Mohd Bashar Momin, Subhash Yadav, Akanksha Chichra, Sachin Punatar, Anant Gokarn, Sumeet Mirgh, Nishant Jindal, Lingaraj Nayak, Lal Hingorani, Navin Khattry, Vikram Gota

    Published 2024-01-01
    Get full text
    Article
  5. 5
    Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation

    Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation by Vijay Shetty, Priyanka Kashelkar, Sachin Punatar, Suhas Haldipurkar, Abhishek Hoshing, Rasika Thakur, Prachi Sankhe, Shabnam Tanwar, Tanvi Haldipurkar, Maninder Singh Setia, Anant Gokarn, Lingaraj Nayak, Avinash Bonda, Navin Khattry

    Published 2024-09-01
    Get full text
    Article
  6. 6
    P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.

    P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES. by Aniket Bhide, Gaurav Chatterjee, Sweta Rajpal, Swapnali Joshi, Vishram Terse, Dhanlaxmi Shetty, Anant Gokarn, Sachin Punatar, Nishant Jindal, Bhausaheb Bagal, Lingaraj Nayak, Hasmukh Jain, Navin Khattry, Manju Sengar, Prashant Tembhare, Sumeet Gujral, Papagudi Subramanian, Nikhil Patkar

    Published 2023-08-01
    Get full text
    Article
  7. 7
    Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax

    Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax by Tarang Gaur, Ramulu Poddutoori, Leena Khare, Bhausaheb Bagal, Sonal Rashmi, Nikhil Patkar, Prashant Tembhare, Subramanian PG, Dhanlaxmi Shetty, Amit Dutt, Qi Zhang, Marina Konopleva, Uwe Platzbeckar, Sudeep Gupta, Susanta Samajdar, Murali Ramchandra, Navin Khattry, Syed K. Hasan

    Published 2023-07-01
    Get full text
    Article
  8. 8
    Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

    Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable resid... by Prashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, Gaurav Chatterjee, Devasis Panda, Sitaram Ghogale, Yajamanam Badrinath, Nilesh Deshpande, Nikhil V Patkar, Gaurav Narula, Bhausaheb Bagal, Hasmukh Jain, Manju Sengar, Navin Khattry, Shripad Banavali, Sumeet Gujral, Papagudi G Subramanian

    Published 2020-05-01
    Get full text
    Article
  9. 9
    P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)

    P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL) by Prashant Tembhare, Simpy Raj, Sitaram Ghogale, Nilesh Deshpande, Karishma Girase, Gaurav Chatterjee, Sweta Rajpal, Nikhil Patkar, Gaurav Narula, Bhausaheb Bagal, Hasmukh Jain, Manju Sengar, Shripad Banavali, Dhanlaxmi Shetty, Chetan Dhamne, Twinkle Khanka, Steffi Varghese, Shaista Jasdanwala, Navin Khattry, Papagudi G Subramanian, Sumeet Gujral

    Published 2023-08-01
    Get full text
    Article
  10. 10
    Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context

    Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context by Nikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, Swapnali Joshi, Shruti Chaudhary, Yajamanam Badrinath, Sitaram Ghoghale, Nilesh Deshpande, Shraddha Kadechkar, Gaurav Chatterjee, Sadhana Kannan, Dhanalaxmi Shetty, Anant Gokarn, Sachin Punatkar, Avinash Bonda, Lingaraj Nayak, Hasmukh Jain, Bhausaheb Bagal, Hari Menon, Manju Sengar, Syed Hasan Khizer, Navin Khattry, Prashant Tembhare, Sumeet Gujral, Papagudi Subramanian

    Published 2019-06-01
    Get full text
    Article
  11. 11
    Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant

    Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant by Prashant R. Tembhare, Harshini Sriram, Twinkle Khanka, Sanghamitra Gawai, Bhausaheb Bagal, Sitaram G. Ghogale, Nilesh Deshpande, Karishma Girase, Jagruti Patil, Syed Khaizer Hasan, Dhanalaxmi Shetty, Kinjalka Ghosh, Gaurav Chatterjee, Sweta Rajpal, Nikhil V. Patkar, Hasmukh Jain, Sachin Punatar, Anant Gokarn, Lingaraj Nayak, Sumeet Mirgh, Nishant Jindal, Manju Sengar, Navin Khattry, Papagudi G. Subramanian, Sumeet Gujral

    Published 2024-04-01
    Get full text
    Article

Search Tools: